(Editor’s note: Missed the earlier ASHG recaps? Find them here! Day One Day Two) In yesterday’s blog, I talked about genetic variability and some concerns about its usefulness. So today, I attended a late evening session, “Clinical Impact of Genetic Variation,” to learn more about how these findings are being used for clinical purposes. The session was led by… Read article →
Posts Tagged: NGS
Do you wonder what you might find if you narrowed your genomic and transcriptomic analyses down to the single-cell level? If you suppressed the noise from ten thousand other cells, what might an individual cell have to say? Single-cell analysis is a burgeoning area of interest, spurred by advances in sequencing technology. Down to the… Read article →
Day 2 of ASHG 2015 opened with a very interesting session on ASHG/ESHG Building Bridges, which focused on perceptions of clinical sequencing in the US and the EU. The 4-member panel included researchers from Columbia University, the US Food and Drug Administration (FDA), the Cyprus Institute of Neurology and Genetics and Our Lady’s Children’s Hospital,… Read article →
Are you using or planning to use RNAseq in your research? If so, please help us understand your needs! Complete the global survey on RNAseq and find out how your fellow scientists are applying RNAseq technology in their research. Take the survey!
Whether you’re studying single cell genomics, circulating tumor cells or the microbiome, analyzing single cells creates the potential for a deeper understanding of cell heterogeneity. But several challenges stand in the way of this goal, such as allelic dropout, coverage uniformity and low yield. How can you overcome these? The single cell team at QIAGEN… Read article →